Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001193125-26-291163

Director sold 1,438,163 shares at an average $34.32 ($49,354,076)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gold Daniel Allen Director 2026-06-26 Sale −300,783 $33.92 $10,202,559 14,826,546 I: show line 1 in the form
Gold Daniel Allen Director 2026-06-26 Sale −325,000 $34.07 $11,072,750 14,501,546 I: show line 2 in the form
Gold Daniel Allen Director 2026-06-29 Sale −200,000 $34.44 $6,888,000 14,301,546 I: show line 3 in the form
Gold Daniel Allen Director 2026-06-29 Sale −600,000 $34.59 $20,754,000 13,701,546 I: show line 4 in the form
Gold Daniel Allen Director 2026-06-30 Sale −12,380 $35.28 $436,766 13,689,166 I: show line 5 in the form
Open-market sales · 1,438,163 sh · avg $34.32 · $49,354,076
Loading xslF345X06/ownership.xml…